Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer.

Improgo MR, Tapper AR, Gardner PD.

Biochem Pharmacol. 2011 Oct 15;82(8):1015-21. doi: 10.1016/j.bcp.2011.05.020. Epub 2011 May 27. Review.

PMID:
21640716
2.

Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.

Egleton RD, Brown KC, Dasgupta P.

Pharmacol Ther. 2009 Feb;121(2):205-23. doi: 10.1016/j.pharmthera.2008.10.007. Epub 2008 Nov 14. Review.

PMID:
19063919
3.

Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis.

Egleton RD, Brown KC, Dasgupta P.

Trends Pharmacol Sci. 2008 Mar;29(3):151-8. doi: 10.1016/j.tips.2007.12.006. Epub 2008 Feb 11. Review.

PMID:
18262664
4.

[Roles of nicotine and nicotinic acetylcholine receptors (nAChR) in carcinogenesis and development of lung cancer].

Guo L, Wu Z, Zhou Q.

Zhongguo Fei Ai Za Zhi. 2011 Sep;14(9):753-7. doi: 10.3779/j.issn.1009-3419.2011.09.10. Review. Chinese. No abstract available.

5.

Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis.

Catassi A, Servent D, Paleari L, Cesario A, Russo P.

Mutat Res. 2008 Sep-Oct;659(3):221-31. doi: 10.1016/j.mrrev.2008.04.002. Epub 2008 Apr 11. Review.

PMID:
18495523
6.

Nicotine, lung and cancer.

Grozio A, Catassi A, Cavalieri Z, Paleari L, Cesario A, Russo P.

Anticancer Agents Med Chem. 2007 Jul;7(4):461-6. Review.

PMID:
17630920
7.

alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?

Paleari L, Cesario A, Fini M, Russo P.

Drug Discov Today. 2009 Sep;14(17-18):822-36. doi: 10.1016/j.drudis.2009.06.016. Epub 2009 Jul 16. Review.

PMID:
19616116
8.

Nicotinic receptor and tobacco-related cancer.

Russo P, Cardinale A, Margaritora S, Cesario A.

Life Sci. 2012 Nov 27;91(21-22):1087-92. doi: 10.1016/j.lfs.2012.05.003. Epub 2012 Jun 15. Review.

PMID:
22705232
9.

The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer.

Improgo MR, Scofield MD, Tapper AR, Gardner PD.

Prog Neurobiol. 2010 Oct;92(2):212-26. doi: 10.1016/j.pneurobio.2010.05.003. Epub 2010 Jun 4. Review.

10.

Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment.

Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C.

Curr Pharm Des. 2016;22(14):2160-9. Review.

PMID:
26845123
11.
12.

Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story.

Dasgupta P, Chellappan SP.

Cell Cycle. 2006 Oct;5(20):2324-8. Epub 2006 Oct 16. Review.

PMID:
17102610
13.

From smoking to lung cancer: the CHRNA5/A3/B4 connection.

Improgo MR, Scofield MD, Tapper AR, Gardner PD.

Oncogene. 2010 Sep 2;29(35):4874-84. doi: 10.1038/onc.2010.256. Epub 2010 Jun 28. Review.

14.
15.

Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.

Schaal C, Chellappan SP.

Mol Cancer Res. 2014 Jan;12(1):14-23. doi: 10.1158/1541-7786.MCR-13-0541. Epub 2014 Jan 7. Review.

16.

Nicotine-induced resistance of non-small cell lung cancer to treatment--possible mechanisms.

Czyżykowski R, Połowinczak-Przybyłek J, Potemski P.

Postepy Hig Med Dosw (Online). 2016 Mar 4;70:186-93. doi: 10.5604/17322693.1196391. Review.

17.

Lung carcinoma signaling pathways activated by smoking.

Wen J, Fu JH, Zhang W, Guo M.

Chin J Cancer. 2011 Aug;30(8):551-8. doi: 10.5732/cjc.011.10059. Review.

18.

Regulatory role of the α7nAChR in cancer.

Schuller HM.

Curr Drug Targets. 2012 May;13(5):680-7. Review.

PMID:
22300035
19.

Acetylcholine receptor pathway and lung cancer.

Thunnissen FB.

J Thorac Oncol. 2009 Aug;4(8):943-6. doi: 10.1097/JTO.0b013e3181ad83fc. Review.

20.

The Oncogenic Functions of Nicotinic Acetylcholine Receptors.

Zhao Y.

J Oncol. 2016;2016:9650481. doi: 10.1155/2016/9650481. Epub 2016 Feb 14. Review.

Supplemental Content

Support Center